Silencing of Long Non‑coding Antisense RNA Brain‑derived Neurotrophic Factor Attenuates Hypoxia/ischemia‑induced Neonatal Brain Injury.

Li-Xing Qiao,Rui-Bin Zhao,Ming-Fu Wu,Li-Hua Zhu,Zheng-Kun Xia
DOI: https://doi.org/10.3892/ijmm.2020.4625
IF: 5.314
2020-01-01
International Journal of Molecular Medicine
Abstract:Hypoxic/ischemic (HI) brain damage (HIBD) is a major cause of acute neonatal brain injury, leading to high mortality and serious neurological deficits. The antisense RNA of brain-derived neurotrophic factor (BDNF-AS) is transcribed from the opposite strand of the BDNF gene. The aim of the present study was to investigate the role of BDNF-AS in HI-induced neuronal cell injuryin vivoandin vitro. Reverse transcription-quantitative PCR (RT-qPCR) assays indicated that BDNF-AS expression was significantly upregulated in HI-injured neonatal brains and hippocampal neurons. However, BDNF expression was downregulated in HI-injured neonatal brains and hippocampal neurons. Cell Counting Kit-8 assays, Hoechst staining, calcein-AM/PI staining, immunostaining, water maze tests and rotarod tests demonstrated that BDNF-AS silencing protected against hypoxia-induced primary hippocampal neuron injuryin vitroand HI-induced brain injuryin vivo. Mechanistically, RT-qPCR assays and western blotting indicated that BDNF-AS silencing led to increased expression of BDNF and activated the BDNF-mediated signaling pathway, as demonstrated by increased expression levels of BDNF, phosphorylated-Akt and phosphorylated-tropomyosin receptor kinase B. Collectively, the present study provides important insights into the pathogenesis of HIBD, and it was indicated that BDNF-AS silencing may be a promising approach for the treatment of neonatal HIBD.
What problem does this paper attempt to address?